Vitality Biopharma Inc. (VBIO)
1.13
-0.06 (5.04%)
Latest Headlines
Valion Bio outlines three-part strategy under new interim CEO
October 21, 2026 8:02 AM - StreetInsider
Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
October 21, 2026 8:01 AM - StreetInsider
Form EFFECT Valion Bio, Inc.
October 21, 2026 6:05 AM - SEC Filing
Form EFFECT Valion Bio, Inc.
October 21, 2026 6:04 AM - SEC Filing
Form 424B3 Valion Bio, Inc.
October 21, 2026 6:02 AM - SEC Filing
Form S-3 Valion Bio, Inc.
October 16, 2026 5:26 PM - SEC Filing
Form DEF 14A Valion Bio, Inc. For: Nov 12
October 16, 2026 4:48 PM - SEC Filing
Valion Bio unit completes early NMR feasibility test with LarmorBio
October 15, 2026 8:06 AM - StreetInsider
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
October 15, 2026 8:01 AM - StreetInsider
Form 8-K Valion Bio, Inc. For: Oct 15
October 15, 2026 8:00 AM - SEC Filing
With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge
October 14, 2026 8:16 AM - StreetInsider
Form 8-K Valion Bio, Inc. For: Oct 14
October 14, 2026 8:15 AM - SEC Filing
Valion Bio develops oral form of radiation countermeasure Entolimod
October 9, 2026 7:51 AM - StreetInsider
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand
October 9, 2026 7:48 AM - StreetInsider
Vitality Biopharma Inc. (VBIO) files $100M mixed shelf
October 8, 2026 6:07 AM - StreetInsider
Form 8-K Valion Bio, Inc. For: Oct 07
October 8, 2026 6:04 AM - SEC Filing
Form S-3 Valion Bio, Inc.
October 8, 2026 6:03 AM - SEC Filing
Form 8-K Valion Bio, Inc. For: Oct 05
October 6, 2026 7:45 AM - SEC Filing
Form PRE 14A Valion Bio, Inc. For: Oct 02
October 5, 2026 10:08 AM - SEC Filing
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
October 5, 2026 8:31 AM - StreetInsider
Form 8-K Valion Bio, Inc. For: Sep 30
October 1, 2026 7:45 AM - SEC Filing
3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
September 30, 2026 10:23 AM - StreetInsider
Form 4 Valion Bio, Inc. For: Sep 22 Filed by: Zikria Dean
September 24, 2026 4:46 PM - SEC Filing
Form 4 Valion Bio, Inc. For: Sep 18 Filed by: Wolf Lisa G
September 24, 2026 4:46 PM - SEC Filing
Valion Bio names board member Dean Zikria as interim CEO
September 23, 2026 8:01 AM - StreetInsider
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
September 23, 2026 8:01 AM - StreetInsider
Form 8-K Valion Bio, Inc. For: Sep 17
September 23, 2026 8:00 AM - SEC Filing
Valion Bio regains Nasdaq minimum bid price compliance
September 22, 2026 8:01 AM - StreetInsider
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
September 22, 2026 8:01 AM - StreetInsider
Form 3 Valion Bio, Inc. For: Aug 27 Filed by: Jensen Thomas
September 17, 2026 4:31 PM - SEC Filing
Form 3 Valion Bio, Inc. For: Aug 27 Filed by: Malbin Jared David
September 17, 2026 4:31 PM - SEC Filing
Valion Bio names CFO Lisa Wolf as president and COO after CEO exits
September 1, 2026 8:01 AM - StreetInsider
Valion Bio Announces Changes to Management and Board of Directors
September 1, 2026 8:01 AM - StreetInsider
Form SCHEDULE 13D/A Valion Bio, Inc. Filed by: 3i, LP
August 27, 2026 8:33 PM - SEC Filing
Valion Bio sets 1-for-25 reverse split to meet Nasdaq rules
August 27, 2026 8:31 AM - StreetInsider
Valion Bio Announces Reverse Stock Split
August 27, 2026 8:31 AM - StreetInsider
Form 8-K Valion Bio, Inc. For: Aug 26
August 27, 2026 8:30 AM - SEC Filing
Form SCHEDULE 13D/A Valion Bio, Inc. Filed by: 3i, LP
August 24, 2026 7:42 PM - SEC Filing
Form RW Valion Bio, Inc.
August 24, 2026 6:05 AM - SEC Filing
Form 8-K/A Valion Bio, Inc. For: Aug 14
August 20, 2026 4:15 PM - SEC Filing
Form SCHEDULE 13D/A Valion Bio, Inc. Filed by: 3i, LP
August 19, 2026 9:09 PM - SEC Filing
Form 8-K Valion Bio, Inc. For: Aug 14
August 17, 2026 6:15 AM - SEC Filing
Form SCHEDULE 13D/A Valion Bio, Inc. Filed by: 3i, LP
August 14, 2026 7:15 PM - SEC Filing
Form 10-Q Valion Bio, Inc. For: Jun 30
August 14, 2026 5:31 PM - SEC Filing
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
August 13, 2026 10:01 AM - StreetInsider
Form EFFECT Valion Bio, Inc.
August 13, 2026 6:06 AM - SEC Filing
AFRRI begins government-funded Entolimod radiation injury study
August 12, 2026 9:32 AM - StreetInsider
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
August 12, 2026 9:32 AM - StreetInsider
Form SCHEDULE 13D/A Valion Bio, Inc. Filed by: 3i, LP
August 11, 2026 4:06 PM - SEC Filing
Form 8-K Valion Bio, Inc. For: Jul 31
August 6, 2026 4:08 PM - SEC Filing
Form SCHEDULE 13D Valion Bio, Inc. Filed by: 3i, LP
August 3, 2026 7:01 AM - SEC Filing
Full Article List
